OptumCare Cancer Care-Research Department ( Site 0005) — Las Vegas, Nevada

OptumCare Cancer Care-Research Department ( Site 0005) is a clinical research site located in Las Vegas, Nevada, United States 89102.

Crixeo Clinical Trials Trust Score: 11/100 (FAILING). This profile has not yet been claimed by the site owner.

OptumCare Cancer Care-Research Department ( Site 0005) has participated in 2 clinical trials with 1 currently active.

Therapeutic areas: Classical Hodgkin Lymphoma, Metastatic Castration-resistant Prostate Cancer (mCRPC), Prostatic Neoplasms.

Sponsors: Merck Sharp & Dohme LLC.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Las Vegas

Browse all research sites in Nevada · View every site in Las Vegas

• University of Nevada at Las Vegas
• University Nevada - Las Vegas
• VA Southern Nevada Healthcare
• Sunrise Hospital
• University of Nevada Las Vegas
• Cure 4 The Kids Foundation, A Division of Roseman University of Health Sciences
• University of Nevada School of Medicine
• Sunrise Hospital/eStudySite
• Valley Hospital and Medical Center
• Sunrise Hospital & Medical Center
• MountianView Hospital
• University of Nevada, Las Vegas (UNLV) School of Medicine

Sponsor Feasibility Report

Trust Score: 11/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for OptumCare Cancer Care-Research Department ( Site 0005)?

OptumCare Cancer Care-Research Department ( Site 0005) has a Crixeo Trust Score of 11/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has OptumCare Cancer Care-Research Department ( Site 0005) conducted?

OptumCare Cancer Care-Research Department ( Site 0005) has 2 clinical trials on record, with 1 currently active. Their work covers Classical Hodgkin Lymphoma, Metastatic Castration-resistant Prostate Cancer (mCRPC), Prostatic Neoplasms.

Is OptumCare Cancer Care-Research Department ( Site 0005) accredited by Crixeo Clinical Trials?

OptumCare Cancer Care-Research Department ( Site 0005) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about OptumCare Cancer Care-Research Department ( Site 0005)?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.